The results of this study indicate that HMGB1 could potentially serve as an innovative biological marker to pinpoint individuals who are more susceptible to experiencing cognitive deterioration following a stroke, and who might gain from timely therapeutic interventions. This evidence concerns the gene HMGB1 and stroke disorder.